Herceptin responsive lung adenocarcinoma in the setting of bilateral synchronous lung primaries and breast carcinoma

Herceptin responsive lung adenocarcinoma in the setting of bilateral synchronous lung primaries and breast carcinoma

The incidence of human epidermal growth factor receptor 2 (Her-2) mutations in lung adenocarcinoma is approximately 3%; however, its significance in the management of these lung cancers remains under investigation. We describe an incidental but unique opportunity to evaluate the response to treatmen...

Full description

Bibliographic Details
Main Authors: Gerard J Fitzmaurice, Michael Moore, Waris Ahmad, Ronan J Ryan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Annals of Thoracic Medicine
Subjects:
Breast carcinoma
herceptin
herceptin responsive adenocarcinoma
synchronous lung primaries
Online Access:http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2017;volume=12;issue=1;spage=57;epage=58;aulast=Fitzmaurice

Internet

http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2017;volume=12;issue=1;spage=57;epage=58;aulast=Fitzmaurice

Similar Items